经剑突下入路与经肋间入路胸腔镜术治疗前纵隔肿瘤的效果差异

doi:10.3969/j.issn.1006-6233.2024.02.028

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1469 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要 目的: 探究经剑突下入路与经肋间入路胸腔镜术对前纵隔肿瘤疗效、并发症的影响。方法: 选2020年1月至2023年1月于宣城市人民医院行胸腔镜手术的前纵隔肿瘤患者100例,根据其手术入路方式将其分为剑突组(经剑突下入路,60例)、肋间组(经肋间入路,40例)。比较两组患者围术期指标(术中出血量、术后引流量、手术时间、镇痛泵使用次数)、康复指标(引流管滞留时间、术后止痛药使用时间、住院时间)、不同时间段疼痛视觉模拟评分(Visual Analog Scale,VAS)以及术后7、15、30、45d Karnofsky功能状态(Karnofsky Performance Status,KPS)评分、并发症(胸腔积液、气胸、肺不张、肺部感染)发生率。结果: 剑突组患者的术中出血量为(24.67±3.21)mL,低于肋间组[(40.13±4.29)mL,P<0.05];术后引流量为(151.95±17.12)mL,低于肋间组[(306.50±30.52)mL,P<0.05];手术时间为(66.00±6.59)min,短于肋间组[(91.65±10.51)min,P<0.05];镇痛泵使用次数为(6.07±1.02)次,低于肋间组[(7.10±1.22)次,P<0.05]。剑突组患者的引流管滞留时间为(17.20±3.19)h,低于肋间组[(21.77±3.97)h,P<0.05];术后止痛药使用时间为(1.85±0.92)d,低于肋间组[(3.10±0.90)d,P<0.05];住院时间为(6.10±1.32)d,低于肋间组[(8.75±1.66)d,P<0.05]。剑突组患者的术前VAS评分为(2.02±0.43)分,与肋间组[(2.00±0.45)分比较无差异,P>0.05];术后1d为(4.57±1.44)分,显著低于肋间组[(5.83±1.48)分,P<0.05];术后2d为(3.00±1.01)分,显著低于肋间组[(4.38±1.39)分,P<0.05];术后3d为(2.40±0.62)分,显著低于肋间组[(3.42±0.81)分,P<0.05]。剑突组患者术后7d的KPS评分为(60.13±3.20)分,显著高于肋间组[(57.38±4.20)分,P<0.05];术后15d为(65.78±3.09)分,显著高于肋间组[(62.17±3.76)分,P<0.05];术后30d为(71.50±3.71)分,显著高于肋间组[(68.10±3.86)分,P<0.05];术后45d为(81.67±5.07)分,显著高于肋间组[(75.45±5.20)分,P<0.05]。并发症总发生率3.33%少于肋间组20.00%,差异有统计学意义(P<0.05)。结论: 经剑突下入路胸腔镜术对前纵隔肿瘤治疗效果理想,能够有效改善患者疼痛及功能状态,减少并发症的发生。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

关键词 ：前纵隔肿瘤, 胸腔镜术, 不同入路, 疗效, 并发症, 影响

Abstract：Objective: To investigate the surgical outcomes and complications of subxiphoid thoracoscopic surgery and intercostal thoracoscopic surgery for anterior mediastinal tumors. Methods: A total of 100 patients with anterior mediastinal tumors who underwent thoracoscopic surgery at Xuancheng People's Hospital from January 2020 to January 2023 were enrolled in this study. According to the surgical approach, the patients were divided into the subxiphoid group (subxiphoid thoracoscopic surgery, 60 cases) and the intercostal group (intercostal thoracoscopic surgery, 40 cases). The perioperative indicators (intraoperative blood loss, postoperative drainage volume, operation time, number of pain pump uses), rehabilitation indicators (drainage tube retention time, postoperative analgesic drug use time, hospital stay), different time points of pain visual analog scale (VAS) scores, and postoperative 7, 15, 30, and 45 days Karnofsky performance status (KPS) scores, and complication rates (pleural effusion, pneumothorax, atelectasis, pulmonary infection) were compared between the two groups. Results: The intraoperative blood loss in the sternotomy group was (24.67±3.21) mL, which was lower than that in the intercostal group [(40.13±4.29)mL, P<0.05]; the postoperative drainage volume was (151.95±17.12) mL, which was lower than that in the intercostal group [(306.50±30.52)mL, P<0.05]; the operation time was (66.00±6.59) min, which was shorter than that in the intercostal group [(91.65±10.51)min, P<0.05]; the number of pain pump uses was (6.07±1.02) times, which was lower than that in the intercostal group [(7.10±1.22)times, P<0.05]. The drainage tube retention time in the sternotomy group was (17.20±3.19) h, which was lower than that in the intercostal group [(21.77±3.97)h, P<0.05]; the postoperative analgesic drug use time was (1.85±0.92) d, which was shorter than that in the intercostal group [(3.10±0.90)d, P<0.05]; the hospital stay was (6.10±1.32) d, which was shorter than that in the intercostal group [(8.75±1.66)d, P<0.05]. The VAS scores of patients in the sternotomy group were (2.02±0.43) points before surgery, which were not significantly different from those in the intercostal group [(2.00±0.45)points, P>0.05]; the VAS scores were (4.57±1.44) points at 1 day after surgery, which were significantly lower than those in the intercostal group [(5.83±1.48)points, P<0.05]; the VAS scores were (3.00±1.01) points at 2 days after surgery, which were significantly lower than those in the intercostal group [(4.38±1.39)points, P<0.05]; the VAS scores were (2.40±0.62) points at 3 days after surgery, which were significantly lower than those in the intercostal group [(3.42±0.81)points, P<0.05]. The KPS score of subxiphophorus group was (60.13±3.20) points at 7 days after operation, which was significantly higher than that of intercostal group [(57.38±4.20) points, P<0.05]. 15 days after surgery, the score was (65.78±3.09), significantly higher than that in intercostal group [(62.17±3.76), P<0.05]. The score at 30d after operation was (71.50±3.71) points, significantly higher than that in intercostal group [(68.10±3.86) points, P<0.05]. The score at 45 days after operation was (81.67±5.07), significantly higher than that in intercostal group [(75.45±5.20), P<0.05]. The total incidence of complications was lower than that of intercostal group, the difference was statistically significant (P<0.05). Conclusion: Thoracoscopy via subxiphoid approach is ideal for the treatment of anterior mediastinal tumors, which can effectively improve patients' pain and functional status and reduce the occurrence of complications.

Key words： Anterior mediastinal tumors Thoracoscopic surgery Different approaches Efficacy Complication Effect

基金资助:安徽省重点研究与开发计划立项项目,(编号:202104a08020074)

引用本文:

李春雷, 方汉林, 方德根. 经剑突下入路与经肋间入路胸腔镜术治疗前纵隔肿瘤的效果差异[J]. 河北医学, 2024, 30(2): 316-321.
LI Chunlei, et al. Comparison of Surgical Outcomes and Complications of Subxiphoid Thoracoscopic Surgery and Intercostal Thoracoscopic Surgery for Anterior Mediastinal Tumors. HeBei Med, 2024, 30(2): 316-321.

链接本文:

http://www.hbyxzzs.cn/CN/10.3969/j.issn.1006-6233.2024.02.028 或 http://www.hbyxzzs.cn/CN/Y2024/V30/I2/316

[1] 陈涛,樊建中,吴彩云,等.成人原发前纵隔恶性肿瘤的多模态成像影像表现及其应用价值[J].河北医科大学学报,2020,41(10):1227-1230.
[2] Nakajima E,Kudo Y,Maehara S,et al.Ruptured mediastinal mature teratoma causing severe mediastinitis:report of a surgically resected case and a literature review[J].Surg Case Rep,2021,7(1):48.
[3] Numanami H,Yano M,Yamaji M,et al.Thoracoscopic thymectomy using a subxiphoid approach for anterior mediastinal tumors[J].Ann Thorac Cardiovasc Surg,2018,24(2):65-72.
[4] 范韶玮,黎涛,夏玉军.电视胸腔镜下纵膈肿瘤切除术中膈神经保护的效果及对手术指标术后恢复的影响[J].河北医学,2021,27(6):1027-1031.
[5] 邹辉,吕小夏,申江峰,等.不同入路胸腔镜下前纵隔肿瘤切除术对患者疼痛应激和生活质量的影响[J].局解手术学杂志,2021,30(8):675-679.
[6] 李子凡,龙飞虎,乌达,等.经剑突下胸腔镜前纵隔肿瘤切除术疗效及远期疼痛分析[J].山西医药杂志,2021,50(3):360-363
[7] 周军正,肖红利,怀琪琳,等.无管化在胸腔镜经剑突下入路治疗老年前纵隔肿瘤中的临床应用[J].老年医学与保健,2021,27(3):500-504.
[8] Chen X,Ma Q,Wang X,et al.Subxiphoid and subcostal thoracoscopic surgical approach for thymectomy[J].Surg Endosc,2021,35(9):5239-5246.
[9] 马云霞,陈何伟,武晓丽.经剑突下入路胸腔镜胸腺切除术中的系统护理支持效果分析[J].河北医药,2022,44(20):3187-3190.
[10] 王洪,曾小飞,贾维坤,等.胸腔镜经剑突下及双侧肋弓下治疗纵隔肿瘤的应用研究[J].局解手术学杂志,2020,29(9):730-733.
[11] 胡英杰,刘晓芯.达芬奇机器人手术与胸腔镜手术治疗前纵膈肿瘤的疗效研究[J].海军医学杂志,2021,42(1):64-67,89.
[12] Amirjamshidi H,Sauer JS,Barrus B,et al.A Novel Subxiphoid Approach for Bilateral Internal Thoracic Artery Harvesting[J].Innovations (Phila),2021,16(2):175-180.